Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

N(1)-methyl-2-lysergic acid diethylamide

Known as: MIL 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Multifunctional ultrafiltration membranes need to be further developed with ultrafiltration performance and high multifunctional… 
2019
2019
Anesthetics, especially propofol, are discussed to influence ischemic preconditioning. We investigated whether cardioprotection… 
  • figure 1
  • table 1
  • figure 2
  • table 2
2019
2019
BACKGROUND Meconium aspiration syndrome (MAS) is a major cause of severe respiratory failure in near- and full-term neonates… 
2005
2005
As M. Rubinstein [Ru] has already considered all primitive quadratic characters with prime conductor q ∈ [N, 2N ], we do not… 
2004
2004
Octadecyl-[2-(N-methylpiperidinio)ethyl]-phosphate (OMPEP, D-20133), a heterocyclic analogue of hexadecylphosphocholine (MIL… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2003
Highly Cited
2003
The antitumor drug miltefosine (hexadecylphosphocholine, MIL) has recently been approved as the first oral agent for the… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2002
2002
The inotropic, chronotropic, and vasodilatory effects of five commonly used cyclic adenosine 3',5'-monophosphate (cAMP… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1994
1994
Seventeen free-ranging red deer (Cervus elaphus) (12 calves and 5 yearling hinds) were immobilized with a combination of… 
  • table 1
  • table 2
  • table 3
1993
1993
Milrinone (MIL; a cAMP-specific phosphodiesterase type-III inhibitor), added in vitro to achieve concentrations below the… 
1987
1987
A model of congestive heart failure (CHF) was produced in rats approximately 76 days following surgical occlusion of the left…